Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;14(7):656-62.
doi: 10.1038/gim.2012.3.

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies

Patricia A Deverka  1 , Sheri D Schully, Naoko Ishibe, Josh J Carlson, Andrew Freedman, Katrina A B Goddard, Muin J Khoury, Scott D Ramsey
Affiliations

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies

Patricia A Deverka et al. Genet Med. 2012 Jul.

Erratum in

  • Genet Med. 2013 Jan;15(1):91

Abstract

Purpose: Insufficient evidence on the net benefits and harms of genomic tests in real-world settings is a translational barrier for genomic medicine. Understanding stakeholders' assessment of the current evidence base for clinical practice and coverage decisions should be a critical step in influencing research, policy, and practice.

Methods: Twenty-two stakeholders participated in a workshop exploring the evidence of genomic tests for clinical and coverage decision making. Stakeholders completed a survey prior to and during the meeting. They also discussed if they would recommend for or against current clinical use of each test.

Results: At baseline, the level of confidence in the clinical validity and clinical utility of each test varied, although the group expressed greater confidence for epidermal growth factor receptor mutation and Lynch syndrome testing than for Oncotype DX. Following the discussion, survey results reflected even less confidence for Oncotype DX, intermediate levels of confidence for [corrected] epidermal growth factor receptor mutation testing and stable levels of confidence [corrected] for Lynch syndrome testing. The majority of stakeholders would consider clinical use for all three tests, but under the conditions of additional research or a shared clinical decision-making approach.

Conclusion: Stakeholder engagement in unbiased settings is necessary to understand various perspectives about evidentiary thresholds in genomic medicine. Participants recommended the use of various methods for evidence generation and synthesis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Stakeholder answers (during the meeting) to “At this time, what recommendation would you make regarding: (A) Oncotype DX; (B) Lynch Syndrome; (C) EGFR
Figure 1
Figure 1
Stakeholder answers (during the meeting) to “At this time, what recommendation would you make regarding: (A) Oncotype DX; (B) Lynch Syndrome; (C) EGFR
See this image and copyright information in PMC

References

    1. Feero WG, Guttmacher AE, Collins FS. Genomic medicine--an updated primer. N Engl J Med. May 27;362(21):2001–2011. - PubMed
    1. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007 Oct;9(10):665–674. - PubMed
    1. Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational research in cancer genetics: the road less traveled. Public Health Genomics. 2011;14(1):1–8. - PMC - PubMed
    1. IOM. [Accessed July 20, 2011];Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary. http://www.iom.edu/Home/Reports/2011/Generating-Evidence-for-Genomic-Dia.... - PubMed
    1. DeStefano FWN, Lux LJ, Lohr KN. [Accessed November 23, 2011, 2011];Infrastructure to Monitor Utilization and Outcomes of Gene-Based Applications: An Assessment. 2008 May; http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-revi....

Publication types

MeSH terms